Vestal Point Capital »

Evommune shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 1.0M 13.29

More positions owned by Vestal Point Capital

BioMarin Pharmaceutical (BMRN)
Neurocrine Biosciences (NBIX)
Abivax SA Sponsored Ads (ABVX)
United Therapeutics Corporation (UTHR)
Enliven Therapeutics (ELVN)
Nurix Therapeutics (NRIX)
Bicara Therapeutics (BCAX)
Taysha Gene Therapies Com Shs (TSHA)
Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories (ABT)
Zimmer Holdings (ZBH)
Disc Medicine (IRON)
Monte Rosa Therapeutics (GLUE)
Insulet Corporation (PODD)
Ascendis Pharma A/S Ord Shs (ASND)

View all positions for Vestal Point Capital

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Jpmorgan Chase & Co
Rtw Investments
Nan Fung Group Holdings
Point72 Asset Management
Andera Partners
SymBiosis Capital Partners
Eventide Asset Management
T. Rowe Price Associates
Vestal Point Capital
Henderson Group
Jupiter Topco
BlackRock

View all funds holding Evommune